Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
3,105
-21
-0.7% -$7.19K 0.51% 52
2026
Q1
$1.1M Buy
3,126
+99
+3% +$35.3K 0.6% 49
2025
Q4
$991K Sell
3,027
-41
-1% -$13K 0.55% 49
2025
Q3
$866K Buy
3,068
+7
+0.2% +$2.03K 0.48% 53
2025
Q2
$855K Buy
3,061
+6
+0.2% +$1.7K 0.52% 55
2025
Q1
$952K Buy
3,055
+493
+19% +$146K 0.66% 51
2024
Q4
$668K Buy
2,562
+93
+4% +$27.6K 0.44% 65
2024
Q3
$795K Buy
2,469
+40
+2% +$13.1K 0.53% 60
2024
Q2
$759K Buy
2,429
+67
+3% +$19.7K 0.54% 58
2024
Q1
$672K Buy
2,362
+147
+7% +$43K 0.49% 67
2023
Q4
$638K Buy
2,215
+61
+3% +$16.6K 0.53% 64
2023
Q3
$579K Buy
+2,154
New +$538K 0.56% 62

Other funds holding AMGN

MWA Asset Management's AMGN Position: Q2 2026 in Review

MWA Asset Management reduced its Amgen (AMGN) stake by 0.67% in Q2 2026, selling an estimated $7.19K and leaving 3,105 shares worth $1.12M. The position accounts for 0.51% of the portfolio, ranked #52.

MWA Asset Management first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MWA Asset Management held 3,105 shares of Amgen worth $1.12M as of Q2 2026.
  • MWA Asset Management sold 21 Amgen shares in Q2 2026, an estimated $7.19K.
  • Amgen made up 0.51% of MWA Asset Management's portfolio in Q2 2026, its #52 holding.
  • MWA Asset Management first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MWA Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.